Insider · CIK 0001238303

LAROSA JOSEPH J

Reports to the SEC for 2 companies · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001238303

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-19	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	+12.3K sh	$381.92	+$4.69M	45,392
2026-08-19	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−9,019 sh	$830.15	−$7.49M	36,373
2026-08-19	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	−12.3K sh	—	—	12,283
2025-12-08	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−1,396 sh	$712.94	−$995K	29,517
2025-12-05	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP General Counsel and Secret	AAward	+2,476 sh	—	—	30,913
2025-12-05	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP General Counsel and Secret	AAward	+12.2K sh	—	—	12,210
2025-11-20	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	+14.5K sh	$555.67	+$8.03M	35,525
2025-11-20	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−12.7K sh	$736.77	−$9.35M	22,839
2025-11-20	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	−14.5K sh	—	—	0
2024-12-16	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−702 sh	$730.81	−$513K	30,075
2024-12-09	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−492 sh	$787.00	−$387K	30,777
2024-12-06	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP General Counsel and Secret	AAward	+2,332 sh	—	—	31,269
2024-12-06	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP General Counsel and Secret	AAward	+8,981 sh	—	—	8,981
2024-07-11	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−1,866 sh	$1088.95	−$2.03M	37,937
2024-06-24	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	+14.5K sh	$555.67	+$8.03M	50,887
2024-06-24	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−11.1K sh	$1060.13	−$11.8M	39,803
2024-06-24	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	−14.5K sh	—	—	14,450
2024-06-10	REGNREGENERON PHARMACEUTICALS, INC.G Gift	EVP General Counsel and Secret	GGift	−1,608 sh	—	—	0
2024-05-21	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−1,865 sh	$994.90	−$1.86M	34,678
2024-02-26	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−1,000 sh	$990.00	−$990K	36,543
2024-02-22	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−1,000 sh	$967.65	−$968K	37,543
2024-02-07	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−1,000 sh	$950.00	−$950K	38,543
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	+34K sh	$399.66	+$13.6M	64,036
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−24.5K sh	$912.30	−$22.3M	39,543
2024-01-03	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	−34K sh	—	—	0
2023-12-11	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−669 sh	$844.09	−$565K	30,036
2023-12-08	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−852 sh	$843.79	−$719K	28,572
2023-12-08	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP General Counsel and Secret	AAward	+2,133 sh	—	—	30,705
2023-12-08	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP General Counsel and Secret	AAward	+7,649 sh	—	—	7,649
2023-03-23	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	+10K sh	$270.43	+$2.7M	34,213
2023-03-23	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−6,742 sh	$801.59	−$5.4M	27,471
2023-03-23	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	−10K sh	—	—	0
2023-03-10	REGNREGENERON PHARMACEUTICALS, INC.G Gift	EVP General Counsel and Secret	GGift	−1,006 sh	—	—	0
2022-12-16	REGNREGENERON PHARMACEUTICALS, INC.A Award	EVP General Counsel and Secret	AAward	+2,752 sh	—	—	23,110
2022-12-16	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)A Award	EVP General Counsel and Secret	AAward	+10.2K sh	—	—	10,159
2022-12-09	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−492 sh	$753.28	−$371K	20,358
2022-09-09	REGNREGENERON PHARMACEUTICALS, INC.M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	+30K sh	$270.43	+$8.11M	41,580
2022-09-09	REGNREGENERON PHARMACEUTICALS, INC.F Tax Payment	EVP General Counsel and Secret	FTax Payment	−20.7K sh	$730.96	−$15.2M	20,850
2022-09-09	REGNREGENERON PHARMACEUTICALS, INC. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP General Counsel and Secret	MExercise/Conversion	−30K sh	—	—	10,000
2022-04-07	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−5,114 sh	$721.10	−$3.69M	16,900
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−369 sh	$685.71	−$253K	26,759
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−557 sh	$686.26	−$382K	26,202
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−497 sh	$687.41	−$342K	25,705
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−799 sh	$688.59	−$550K	24,906
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−218 sh	$689.43	−$150K	24,688
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−250 sh	$690.51	−$173K	24,438
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−641 sh	$691.44	−$443K	23,797
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−195 sh	$692.54	−$135K	23,602
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−567 sh	$693.92	−$393K	23,035
2022-04-01	REGNREGENERON PHARMACEUTICALS, INC.S Sale	EVP General Counsel and Secret	SSale	−259 sh	$694.56	−$180K	22,776

Recent filings

Accepted (ET)
Aug 214
LAROSA JOSEPH J0001238303-26-000002
SEC(opens sec.gov)
Dec 94
LAROSA JOSEPH J0001238303-25-000007
SEC(opens sec.gov)
Nov 244
LAROSA JOSEPH J0001238303-25-000005
SEC(opens sec.gov)
Dec 184
LAROSA JOSEPH J0001883850-24-000062
SEC(opens sec.gov)
Dec 104
LAROSA JOSEPH J0001968202-24-000135
SEC(opens sec.gov)
Jul 124
LAROSA JOSEPH J0001968202-24-000107
SEC(opens sec.gov)
Jun 254
LAROSA JOSEPH J0001883850-24-000036
SEC(opens sec.gov)
Jun 124
LAROSA JOSEPH J0001883850-24-000032
SEC(opens sec.gov)
May 224
LAROSA JOSEPH J0001968202-24-000096
SEC(opens sec.gov)
Feb 284
LAROSA JOSEPH J0001968202-24-000080
SEC(opens sec.gov)

Companies

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591